Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Genus (GNS) Share Price

Price 2,475.00p on 25-07-2025 at 18:40:06
Change 25.00p 1.02%
Buy 2,470.00p
Sell 2,460.00p
Last Trade: Buy 29,246.00 at 2,475.00p
Day's Volume: 681,977
Last Close: 2,475.00p
Open: 2,445.00p
ISIN: GB0002074580
Day's Range 2,435.00p - 2,490.00p
52wk Range: 1,424.00p - 2,490.00p
Market Capitalisation: £1.63b
VWAP: 2,470.0902p
Shares in Issue: 65.69m

Genus (GNS) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 29,246 2,475.00p Suspected BUY Trade
16:35:20 - 25-Jul-25
Sell* 111 2,465.00p Automatic Execution
16:28:40 - 25-Jul-25
Sell* 103 2,465.00p Automatic Execution
16:28:40 - 25-Jul-25
Sell* 55 2,465.00p Automatic Execution
16:28:39 - 25-Jul-25
Sell* 38 2,470.00p Automatic Execution
16:27:14 - 25-Jul-25
Sell* 162 2,470.00p Automatic Execution
16:27:14 - 25-Jul-25
Buy* 38 2,470.00p Automatic Execution
16:27:14 - 25-Jul-25
Buy* 125 2,470.00p Automatic Execution
16:27:14 - 25-Jul-25
Sell* 31 2,465.00p Automatic Execution
16:27:14 - 25-Jul-25
Sell* 62 2,465.00p Automatic Execution
16:27:14 - 25-Jul-25
See more Genus trades

Genus (GNS) Share Price History

Time period:
to
Date Open High Low Close Volume
25th Jul 2025 (Fri) 2,445.00 2,490.00 2,435.00 2,475.00 681,977
24th Jul 2025 (Thu) 2,440.00 2,460.00 2,435.00 2,450.00 249,861
23rd Jul 2025 (Wed) 2,420.00 2,440.00 2,400.00 2,410.00 247,870
22nd Jul 2025 (Tue) 2,480.00 2,480.00 2,395.00 2,420.00 73,383
21st Jul 2025 (Mon) 2,400.00 2,430.00 2,395.00 2,410.00 50,640
18th Jul 2025 (Fri) 2,440.00 2,440.00 2,400.00 2,400.00 80,412
17th Jul 2025 (Thu) 2,375.00 2,445.00 2,375.00 2,420.00 293,813
16th Jul 2025 (Wed) 2,410.00 2,485.00 2,385.00 2,385.00 359,021
15th Jul 2025 (Tue) 2,240.00 2,435.00 2,235.00 2,410.00 144,946
14th Jul 2025 (Mon) 2,250.00 2,250.00 2,215.00 2,235.00 91,089
11th Jul 2025 (Fri) 2,180.00 2,225.00 2,175.00 2,220.00 120,099
10th Jul 2025 (Thu) 2,210.00 2,240.00 2,155.00 2,195.00 61,275
9th Jul 2025 (Wed) 2,085.00 2,215.00 2,085.00 2,205.00 634,531
8th Jul 2025 (Tue) 2,125.00 2,150.00 2,105.00 2,130.00 60,056
7th Jul 2025 (Mon) 2,080.00 2,165.00 2,080.00 2,130.00 41,628
4th Jul 2025 (Fri) 2,160.00 2,160.00 2,120.00 2,125.00 74,094
3rd Jul 2025 (Thu) 2,040.00 2,180.00 1,994.00 2,155.00 155,901
2nd Jul 2025 (Wed) 2,015.00 2,015.00 1,984.00 1,998.00 97,747
1st Jul 2025 (Tue) 2,085.00 2,085.00 1,972.00 2,020.00 125,495
30th Jun 2025 (Mon) 2,005.00 2,050.00 2,005.00 2,045.00 212,689
27th Jun 2025 (Fri) 1,964.00 2,065.00 1,964.00 2,045.00 78,187
26th Jun 2025 (Thu) 1,940.00 1,976.00 1,924.00 1,966.00 178,764
See more Genus price history

Genus (GNS) Regulatory News

Date Source Headline
15th Jul 2025 7:00 am RNS FY25 Trading Update
9th May 2025 9:25 am RNS Appointment of Financial Adviser & joint Broker
1st May 2025 2:28 pm RNS Total Voting Rights
30th Apr 2025 7:00 am RNS PRRS Resistant Pig – FDA Approval
25th Apr 2025 4:30 pm RNS Notification of Major Holdings
25th Apr 2025 4:28 pm RNS Notification of Major Holdings
2nd Apr 2025 5:08 pm RNS Director/PDMR Shareholding
2nd Apr 2025 3:43 pm RNS Notification of Major Holdings
13th Mar 2025 7:00 am RNS Appointment of Chief Financial Officer Designate
3rd Mar 2025 11:32 am RNS Total Voting Rights
See more Genus regulatory news

Genus (GNS) Share News

LONDON BROKER RATINGS: Morgan Stanley raises Hiscox and cuts Hays

16th Jul 2025 09:45

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

Genus shares rise as expects annual profit to beat analyst consensus

15th Jul 2025 09:47

(Alliance News) - Genus PLC on Tuesday reported good trading as it expects annual adjusted pretax profit to come in higher than the upper end of analyst estimates. Read More

IN BRIEF: Genus gets US FDA approval for disease-resistant pigs

30th Apr 2025 14:59

Genus PLC - Basingstoke, England-based animal biotechnology and genetics company - Gets US Food & Drug Administration approval for its 'PRRS resistant pig' gene edit for use in the US food supply chain. PRRS stands for porcine reproductive and respiratory syndrome, a disease that causes suffering and premature death for pigs. Genus says the success with the US FDA follows "years of close collaboration". It now is seeking approvals for the PRP programme in key US export markets, including Canada, Mexico and Japan. It also is making progress with regulators in China and elsewhere. Brazil, Colombia and Dominican Republic already have approved PRP. Read More

LONDON MARKET MIDDAY: Stocks up as earnings come "thick and fast"

30th Apr 2025 12:05

(Alliance News) - Stock prices in London were higher at midday on Wednesday, while overseas data from Eurostat showed the eurozone economy expanding faster than expected. Read More

LONDON MARKET OPEN: Stocks up; Smith & Nephew leads with revenue rise

30th Apr 2025 09:03

(Alliance News) - Stock prices in London opened higher on Wednesday, ahead of US and eurozone GDP data releases. Read More

See more Genus news
FTSE 100 Latest
Value9,120.31
Change-18.06

Login to your account

Forgot Password?

Not Registered